Literature DB >> 28440733

Morphological and morphometric analysis of the effects of intralesional tamoxifen on keloids.

Lauro R Soares-Lopes1,2, Ione M Soares-Lopes1,3, Lauro Ll Filho1,2, Airlane P Alencar4, Benedito B da Silva1,3.   

Abstract

The aim of this study was to evaluate the effect of intralesional tamoxifen on keloids, particularly on the concentration of fibroblasts, dermal inflammatory infiltrate, and collagen degeneration. A prospective study was carried out to evaluate keloids in 13 patients of both genders pre- and post-treatment with intralesional tamoxifen. Two samples of keloid lesions were obtained by 4-mm punch biopsies during the study: the first at the time of diagnostic confirmation of keloid and the other eight weeks later at the end of intralesional tamoxifen treatment. The biopsy samples were placed in 10% buffered formalin for HE staining and morphological and morphometric study. The degree of collagen fiber reduction and inflammatory infiltration were analyzed. Student's t-test was used for statistical analysis of the mean number of fibroblasts before and following tamoxifen treatment ( P < 0.05). The degree of collagen fiber reduction and inflammatory infiltration were absent before treatment and present in 100% of cases after treatment, while the mean number of fibroblasts was significantly lower after intralesional tamoxifen treatment ( P < 0.0001). We conclude that intralesional administration of tamoxifen promoted an inflammatory stimulus and collagen fiber reduction as well as a significant reduction in the number of fibroblasts that produce collagen. Impact statement Effective treatment of keloid that is a commonly recurrent dermatosis is very difficult, even after standard treatment. Standard treatment consists of partial resection of the lesion (shaving excision), in addition to local corticosteroid injection. Therefore, there is interest in alternative forms of topical treatment, e.g., selective estrogen receptor modulators, particularly tamoxifen has demonstrated in vitro studies to be a promising drug. Nevertheless, there is scarcity of publications on the effects of intralesional tamoxifen on keloids have been found, leading us to the conception of the present study. In this study, tamoxifen has proven to be an interesting alternative drug for the topical treatment of keloid, allowing us to conclude that the intralesional application of tamoxifen in keloids promotes a variable but ever-present inflammatory stimulus, associated with intense reduction of collagen fiber, in addition to a significant decrease in the number of fibroblasts that produce collagen and are involved in disease maintenance.

Entities:  

Keywords:  Tamoxifen; collagen fibroblasts; fibrosis; inflammatory infiltration; keloid; skin

Mesh:

Substances:

Year:  2017        PMID: 28440733      PMCID: PMC5407593          DOI: 10.1177/1535370217700524

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  14 in total

Review 1.  Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature.

Authors:  Douglas Leventhal; Maxwell Furr; David Reiter
Journal:  Arch Facial Plast Surg       Date:  2006 Nov-Dec

2.  The relationship between keloid growth pattern and stretching tension: visual analysis using the finite element method.

Authors:  Satoshi Akaishi; Masataka Akimoto; Rei Ogawa; Hiko Hyakusoku
Journal:  Ann Plast Surg       Date:  2008-04       Impact factor: 1.539

3.  Tamoxifen downregulates TGF-beta production in keloid fibroblasts.

Authors:  D Chau; J S Mancoll; S Lee; J Zhao; L G Phillips; G K Gittes; M T Longaker
Journal:  Ann Plast Surg       Date:  1998-05       Impact factor: 1.539

4.  Effects of tamoxifen on normal human dermal fibroblasts.

Authors:  Mauro B Ruffy; Shaun S Kunnavatana; R James Koch
Journal:  Arch Facial Plast Surg       Date:  2006 Sep-Oct

5.  Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts.

Authors:  A A Mikulec; M M Hanasono; J Lum; J M Kadleck; M Kita; R J Koch
Journal:  Arch Facial Plast Surg       Date:  2001 Apr-Jun

6.  Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues.

Authors:  Luigi Rossiello; Francesco D'Andrea; Roberto Grella; Giuseppe Signoriello; Ciro Abbondanza; Caterina De Rosa; Mariaevelina Prudente; Marianna Morlando; Raffaele Rossiello
Journal:  Wound Repair Regen       Date:  2009 Sep-Oct       Impact factor: 3.617

Review 7.  Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.

Authors:  Heidi D Nelson; Rongwei Fu; Jessica C Griffin; Peggy Nygren; M E Beth Smith; Linda Humphrey
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

8.  Topical tamoxifen therapy in hypertrophic scars or keloids in burns.

Authors:  Alfredo Gragnani; Mario Warde; Fabianne Furtado; Lydia Masako Ferreira
Journal:  Arch Dermatol Res       Date:  2009-07-28       Impact factor: 3.017

9.  [The inhibitory effect of tamoxifen on human dermal fibroblast-populated collagen lattices].

Authors:  Dahai Hu; Xiongxiang Zhu; Mingda Xu; Bi Chen; A H Margaret; W C George
Journal:  Zhonghua Zheng Xing Wai Ke Za Zhi       Date:  2002-05

10.  Keloid scars are formed by polyclonal fibroblasts.

Authors:  Pierre M Chevray; Paul N Manson
Journal:  Ann Plast Surg       Date:  2004-06       Impact factor: 1.539

View more
  1 in total

Review 1.  Managing keloid scars: From radiation therapy to actual and potential drug deliveries.

Authors:  Chenyu Huang; Longwei Liu; Zhifeng You; Yanan Du; Rei Ogawa
Journal:  Int Wound J       Date:  2019-03-12       Impact factor: 3.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.